Trials
Search / Trial NCT06437795

Effectiveness of Dry Needling Versus Cupping Therapy for Pain in Piriformis Syndrome

Launched by SUPERIOR UNIVERSITY · May 25, 2024

Apply for Trial

Trial Information

Current as of March 13, 2025

Active, not recruiting

Keywords

ClinConnect Summary

The study will recruit participants diagnosed with Piriformis Syndrome and will randomly assign them to receive either dry needling or cupping therapy over a specific period. The primary outcome will be the reduction in pain intensity measured by standardized pain assessment tools. Secondary outcomes will include improvements in functional mobility and quality of life. By analyzing the efficacy and patient-reported outcomes of both therapies, the study aims to provide evidence-based recommendations for clinicians treating Piriformis Syndrome.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Adults aged between 18 to 65 years.
  • • Diagnosed with piriformis syndrome.
  • • Experiencing chronic pain for at least 3 months.
  • • Willingness to comply with the study protocol and attend all therapy sessions.
  • Exclusion Criteria:
  • • Recent surgery on the lower back or hip.
  • • Presence of systemic diseases affecting muscle function (e.g., multiple sclerosis, rheumatoid arthritis).
  • • Pregnant or breastfeeding women.
  • • Use of anticoagulant medication or having a bleeding disorder.
  • • Participating in another clinical trial simultaneously

About Superior University

Superior University is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to excellence in education and patient care, the university fosters a collaborative environment that brings together multidisciplinary teams of researchers, clinicians, and students. Superior University is focused on exploring novel therapeutic approaches and improving patient outcomes, leveraging its state-of-the-art facilities and cutting-edge technology. The institution adheres to the highest ethical standards and regulatory guidelines, ensuring the integrity and impact of its clinical research initiatives.

Locations

Lahore, Punjab, Pakistan

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0